Biweekly docetaxel and carboplatin as first-line therapy in patients with advanced non-small cell lung cancer (NSCLC). Finally results of a phase II study

被引：0
|
作者：
Firvida, J. L.
Esquerdo, G.
Amenedo, M.
Salgado, M.
LLorca, C.
Perez, E.
Cervera Grau, J.
Ramos, M.
机构：
[1] Complejo Hosp Ourense, Orense, Spain
[2] Ctr Oncol A Coruna, La Coruna, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19097
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19097
引用
收藏
页数：1
相关论文
共 50 条
  • [1] BIWEEKLY CARBOPLATIN AND PACLITAXEL AS FIRST-LINE THERAPY FOR ELDERLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS (PHASE II STUDY)
    Kota, I.
    Soejima, K.
    Naoki, K.
    Yasuda, H.
    Terai, H.
    Daisuke, A.
    Ohgino, K.
    Yoda, S.
    Ikemura, S.
    Betsuyaku, T.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 422 - 422
  • [2] Phase II study of meloxicam with carboplatin plus docetaxel in first-line treatment of patients with advanced non-small cell lung cancer (NSCLC)
    Ishida, T.
    Kanazawa, K.
    Oizumi, H.
    Yokouchi, H.
    Yamazaki, K.
    Akie, K.
    Sukoh, N.
    Harada, M.
    Munakata, M.
    Isobe, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: A phase II study
    Jahanzeb, M
    Sarna, G
    Hirsch, R
    Radice, P
    Koletsky, A
    Martinez, M
    Kruglyak, E
    Wolin, E
    Camacho, E
    Kronish, L
    Motl, S
    [J]. ANTICANCER RESEARCH, 2004, 24 (2C) : 1239 - 1242
  • [4] Phase II study of biweekly carboplatin and paclitaxel as first-line treatment for elderly patients with advanced non-small cell lung cancer
    Terai, H.
    Soejima, K.
    Nakamura, M.
    Naoki, K.
    Yasuda, H.
    Satomi, R.
    Nakayama, S.
    Yoda, S.
    Ikemura, S.
    Sato, T.
    Asano, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in elderly non-small cell lung cancer (NSCLC) patients.
    Llorca, C.
    Esquerdo, G.
    Munoz, J., Sr.
    Sanchez-Hernandez, A.
    Gomez-Codina, J.
    Juan Vidal, O.
    Macia, S.
    Catot, S.
    Giner, V.
    Aparisi, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Biweekly docetaxel as first-line therapy in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) 2: A phase II study of the Galician Lung Cancer Group
    Vazquez-Estevez, S.
    Leon, L.
    Firvida, J. L.
    Grande, C.
    Vazquez, F.
    Salgado, M.
    Casal, J.
    Baron, F. J.
    Abal, J.
    Garcia, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer
    Ishimoto, Osamu
    Sugawara, Shunichi
    Inoue, Akira
    Ishida, Takashi
    Munakata, Mitsuru
    Koinumaru, Sadahiro
    Hasegawa, Yukihiro
    Suzuki, Toshiro
    Miki, Hiroshi
    Saijo, Yasuo
    Nukiwa, Toshihiro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (09) : 979 - 983
  • [8] Phase II study of docetaxel and oxaliplatin in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer (NSCLC).
    Raez, L. E.
    Brito, R.
    Kobina, S.
    Perdekamp, M. G.
    Karr, M.
    Santos, E. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Docetaxel (Taxotere®) as first-line therapy of advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    [J]. ONKOLOGIE, 2003, 26 : 26 - 32
  • [10] BIWEEKLY AND CARBOPLATIN(CBDCA) AND PACLITAXEL(PTX) AS FIRST-LINE IS HOPEFUL THERAPY IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: PRELIMINARY RESULTS OF A PHASE II STUDY
    Terai, Hideki
    Soejima, Kenzo
    Nakamura, Morio
    Naoki, Katsuhiko
    Watanabe, Hideo
    Kawada, Ichiro
    Nakachi, Ichiro
    Yasuda, Hiroyuki
    Nakayama, Souhei
    Satomi, Ryousuke
    Yoda, Satoshi
    Ikemura, Shinnosuke
    Sato, Takashi
    Asano, Kouichirou
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1195 - S1196
12345